Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma

Hamid Nikbakht(McGill University and Génome Québec Innovation Centre), Eshini Panditharatna(Children's National), Leonie G. Mikael(McGill University Health Centre), Rui Li(McGill University and Génome Québec Innovation Centre), Tenzin Gayden(McGill University), Matthew Osmond(McGill University and Génome Québec Innovation Centre), Cheng‐Ying Ho(Children's National), Madhuri Kambhampati(Children's National), Eugene Hwang(Children's National), Damien Faury(McGill University Health Centre), Alan Siu(George Washington University), Simon Papillon‐Cavanagh(McGill University and Génome Québec Innovation Centre), Denise Béchet(McGill University), Keith L. Ligon(Dana-Farber Cancer Institute), Benjamin Ellezam(Centre Hospitalier Universitaire Sainte-Justine), Wendy J. Ingram(The University of Queensland), Caedyn L. Stinson(The University of Queensland), Andrew S. Moore(The University of Queensland), Katherine E. Warren(National Cancer Institute), Jason Karamchandani(Montreal Neurological Institute and Hospital), Roger J. Packer(Children's National), Nada Jabado(McGill University Health Centre), Jacek Majewski(McGill University and Génome Québec Innovation Centre), Javad Nazarian(Children's National)
Nature Communications
April 6, 2016
Cited by 262Open Access
Full Text

Abstract

Diffuse Intrinsic Pontine Gliomas (DIPGs) are deadly paediatric brain tumours where needle biopsies help guide diagnosis and targeted therapies. To address spatial heterogeneity, here we analyse 134 specimens from various neuroanatomical structures of whole autopsy brains from nine DIPG patients. Evolutionary reconstruction indicates histone 3 (H3) K27M--including H3.2K27M--mutations potentially arise first and are invariably associated with specific, high-fidelity obligate partners throughout the tumour and its spread, from diagnosis to end-stage disease, suggesting mutual need for tumorigenesis. These H3K27M ubiquitously-associated mutations involve alterations in TP53 cell-cycle (TP53/PPM1D) or specific growth factor pathways (ACVR1/PIK3R1). Later oncogenic alterations arise in sub-clones and often affect the PI3K pathway. Our findings are consistent with early tumour spread outside the brainstem including the cerebrum. The spatial and temporal homogeneity of main driver mutations in DIPG implies they will be captured by limited biopsies and emphasizes the need to develop therapies specifically targeting obligate oncohistone partnerships.


Related Papers

No related papers found

Powered by citation graph analysis